Mutations strengthened SARS-CoV-2 infectivity
Jiahui Chen, Rui Wang, Menglun Wang, and Guo-Wei Wei

TL;DR
This study uses a novel algebraic topology-based machine learning approach to evaluate how mutations in SARS-CoV-2 affect its infectivity, revealing that most subtypes are becoming more infectious and predicting key residues likely to mutate further.
Contribution
The paper introduces an advanced topological machine learning method to systematically assess mutation impacts on SARS-CoV-2 infectivity, providing insights into future mutation risks.
Findings
Most SARS-CoV-2 subtypes are becoming more infectious.
SARS-CoV-2 is slightly more infectious than SARS-CoV.
Certain residues are highly likely to mutate into more infectious strains.
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity is a major concern in coronavirus disease 2019 (COVID-19) prevention and economic reopening. However, rigorous determination of SARS-COV-2 infectivity is essentially impossible owing to its continuous evolution with over 13752 single nucleotide polymorphisms (SNP) variants in six different subtypes. We develop an advanced machine learning algorithm based on the algebraic topology to quantitatively evaluate the binding affinity changes of SARS-CoV-2 spike glycoprotein (S protein) and host angiotensin-converting enzyme 2 (ACE2) receptor following the mutations. Based on mutation-induced binding affinity changes, we reveal that five out of six SARS-CoV-2 subtypes have become either moderately or slightly more infectious, while one subtype has weakened its infectivity. We find that SARS-CoV-2 is slightly more…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsSARS-CoV-2 and COVID-19 Research · vaccines and immunoinformatics approaches · Computational Drug Discovery Methods
